• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响急性中心性浆液性脉络膜视网膜病变病例发作持续时间以及解剖和功能转归的因素。

Factors influencing the episode duration and the anatomical and functional outcome in cases of acute central serous chorioretinopathy.

作者信息

Parajuli Anil, Joshi Purushottam

机构信息

Glaucoma, Mechi Eye Hospital, Birtamode, Nepal.

Retina, Pediatric Ophthalmolgy and Strabismus, Cataract, Mechi Eye Hospital, Birtamode, Nepal.

出版信息

BMJ Open Ophthalmol. 2020 Dec 1;5(1):e000540. doi: 10.1136/bmjophth-2020-000540. eCollection 2020.

DOI:10.1136/bmjophth-2020-000540
PMID:33305002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7709512/
Abstract

OBJECTIVE

To investigate the factors affecting the duration of subretinal fluid (SRF) resolution and their correlation with the final anatomical and functional outcome in cases of treatment naïve acute central serous chorioretinopathy (CSCR).

METHODS AND ANALYSIS

We retrospectively studied 93 eyes of 93 patients diagnosed with treatment naïve acute CSCR presenting within 30 days of onset of symptoms. The eyes were divided into two groups (1 and 2) based on the duration of SRF resolution; which was ≤3 months in group 1 and >3 months in group 2. Demographic and medical history, and spectral domain optical coherence tomography features were noted and their association with duration for SRF resolution, final central macular thickness (CMT) and final best-corrected visual acuity (BCVA) were studied. All the patients were prescribed topical non-steroidal anti-inflammatory drug for 1 month at the diagnosis of CSCR.

RESULTS

Longer duration of symptoms, female gender and baseline OCT factors like hyper-reflective dots and retinal pigment epithelial bumps were associated with longer duration for SRF resolution (p<0.001, p=0.04, p=0.001 and p=0.01, respectively). The SRF resolution time had strong correlations with the final CMT (r=-0.589, p<0.001) and final BCVA in logarithm of minimum angle of resolution (LogMAR) (r=+0.599, p<0.001). Group 2 eyes had worse final BCVA and thinner final CMT than Group 1 (both p<0.001). The final CMT of the patients of Group 1 was statistically thinner than the normal population (p<0.001).

CONCLUSION

Patient's baseline clinicodemographic and OCT features can be used to predict the course and visual outcome in cases of treatment naïve acute idiopathic CSCR.

摘要

目的

探讨初治急性中心性浆液性脉络膜视网膜病变(CSCR)患者视网膜下液(SRF)消退时间的影响因素及其与最终解剖和功能结局的相关性。

方法与分析

我们回顾性研究了93例初治急性CSCR患者的93只眼,这些患者在症状出现后30天内就诊。根据SRF消退时间将这些眼分为两组(1组和2组);1组SRF消退时间≤3个月,2组>3个月。记录人口统计学和病史以及频域光学相干断层扫描特征,并研究它们与SRF消退时间、最终中心黄斑厚度(CMT)和最终最佳矫正视力(BCVA)的相关性。所有患者在诊断CSCR时均接受局部非甾体抗炎药治疗1个月。

结果

症状持续时间较长、女性性别以及基线OCT因素如高反射点和视网膜色素上皮隆起与SRF消退时间较长相关(分别为p<0.001、p=0.04、p=0.001和p=0.01)。SRF消退时间与最终CMT(r=-0.589,p<0.001)和以最小分辨角对数表示的最终BCVA(r=+0.599,p<0.001)密切相关。2组眼的最终BCVA比1组差,最终CMT比1组薄(均p<0.001)。1组患者的最终CMT在统计学上比正常人群薄(p<0.001)。

结论

患者的基线临床人口统计学和OCT特征可用于预测初治急性特发性CSCR患者的病程和视力结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb0/7709512/bcf625b15dd7/bmjophth-2020-000540f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb0/7709512/8a1db8963632/bmjophth-2020-000540f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb0/7709512/bcf625b15dd7/bmjophth-2020-000540f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb0/7709512/8a1db8963632/bmjophth-2020-000540f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8fb0/7709512/bcf625b15dd7/bmjophth-2020-000540f02.jpg

相似文献

1
Factors influencing the episode duration and the anatomical and functional outcome in cases of acute central serous chorioretinopathy.影响急性中心性浆液性脉络膜视网膜病变病例发作持续时间以及解剖和功能转归的因素。
BMJ Open Ophthalmol. 2020 Dec 1;5(1):e000540. doi: 10.1136/bmjophth-2020-000540. eCollection 2020.
2
Ganglion Cell Loss in the Course of Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变病程中的神经节细胞丢失
Ophthalmol Ther. 2023 Feb;12(1):517-533. doi: 10.1007/s40123-022-00625-5. Epub 2022 Dec 12.
3
One year outcome and predictors of treatment outcome in central serous chorioretinopathy: Multimodal imaging based analysis.中心性浆液性脉络膜视网膜病变的一年结局及治疗结局预测因素:基于多模态成像的分析
Eur J Ophthalmol. 2022 Jul;32(4):2319-2327. doi: 10.1177/11206721211055018. Epub 2021 Nov 6.
4
Short Term Presence of Subretinal Fluid in Central Serous Chorioretinopathy Affects Retinal Thickness and Function.中心性浆液性脉络膜视网膜病变中视网膜下液的短期存在影响视网膜厚度和功能。
J Clin Med. 2020 Oct 26;9(11):3429. doi: 10.3390/jcm9113429.
5
Optical Coherence Tomography Parameters as Predictors of Treatment Response to Eplerenone in Central Serous Chorioretinopathy.光学相干断层扫描参数作为中心性浆液性脉络膜视网膜病变中依普利酮治疗反应的预测指标
J Clin Med. 2019 Aug 22;8(9):1271. doi: 10.3390/jcm8091271.
6
Baseline Predictive Factors of Visual Outcome and Persistence of Subretinal Fluid Based on Morphologic Changes in Spectral Domain Optical Coherence Tomography in Patients with Idiopathic Central Serous Chorioretinopathy.基于特发性中心性浆液性脉络膜视网膜病变患者光谱域光学相干断层扫描形态学变化的视力预后和视网膜下液持续存在的基线预测因素
Clin Ophthalmol. 2019 Dec 9;13:2439-2444. doi: 10.2147/OPTH.S233273. eCollection 2019.
7
Oral Mineralocorticoid-Receptor Antagonists: Choroidal Parameters Changes Using OCT in Central Serous Chorioretinopathy.口服盐皮质激素受体拮抗剂:中心性浆液性脉络膜视网膜病变中使用光学相干断层扫描观察脉络膜参数变化
Ophthalmic Surg Lasers Imaging Retina. 2019 Nov 1;50(11):726-733. doi: 10.3928/23258160-20191031-08.
8
Visual acuity correlates with multimodal imaging-based categories of central serous chorioretinopathy.视力与基于多模态成像的中心性浆液性脉络膜视网膜病变分类相关。
Eye (Lond). 2022 Mar;36(3):517-523. doi: 10.1038/s41433-021-01788-4. Epub 2021 Oct 13.
9
Anatomical and Functional Changes of the Retina and the Choroid after Resolved Chronic CSCR.慢性中心性浆液性脉络膜视网膜病变消退后视网膜和脉络膜的解剖及功能变化
J Clin Med. 2019 Apr 7;8(4):474. doi: 10.3390/jcm8040474.
10
Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.慢性中心性浆液性脉络膜视网膜病变消退后的视力和视网膜形态损害
BMC Ophthalmol. 2019 Jul 25;19(1):160. doi: 10.1186/s12886-019-1171-5.

引用本文的文献

1
Influence of vortex vein engorgement for photodynamic therapy in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变光动力疗法中涡静脉淤血的影响。
Sci Rep. 2024 Oct 18;14(1):24424. doi: 10.1038/s41598-024-75506-x.
2
Association of Subretinal Fluid Duration and Baseline Chorioretinal Structure With Optical Coherence Tomography in Central Serous Chorioretinopathy.中心性浆液性脉络膜视网膜病变中视网膜下液持续时间和基线脉络膜视网膜结构与光相干断层扫描的相关性。
Transl Vis Sci Technol. 2023 Oct 3;12(10):12. doi: 10.1167/tvst.12.10.12.
3
Effects of Ketoconazole on the Clinical Recovery in Central Serous Chorioretinopathy.

本文引用的文献

1
Baseline Predictive Factors of Visual Outcome and Persistence of Subretinal Fluid Based on Morphologic Changes in Spectral Domain Optical Coherence Tomography in Patients with Idiopathic Central Serous Chorioretinopathy.基于特发性中心性浆液性脉络膜视网膜病变患者光谱域光学相干断层扫描形态学变化的视力预后和视网膜下液持续存在的基线预测因素
Clin Ophthalmol. 2019 Dec 9;13:2439-2444. doi: 10.2147/OPTH.S233273. eCollection 2019.
2
Treatment of central serous chorioretinopathy with topical NSAIDs.局部应用非甾体抗炎药治疗中心性浆液性脉络膜视网膜病变。
Clin Ophthalmol. 2019 Aug 15;13:1543-1548. doi: 10.2147/OPTH.S202047. eCollection 2019.
3
酮康唑对中心性浆液性脉络膜视网膜病变临床恢复的影响。
Clin Ophthalmol. 2022 Jun 9;16:1871-1882. doi: 10.2147/OPTH.S368427. eCollection 2022.
Correlation between baseline retinal microstructures in spectral-domain optic coherence tomography and need for early intervention in central serous chorioretinopathy.
频域光学相干断层扫描中基线视网膜微结构与中心性浆液性脉络膜视网膜病变早期干预需求之间的相关性。
BMJ Open Ophthalmol. 2017 Aug 16;2(1):e000054. doi: 10.1136/bmjophth-2016-000054. eCollection 2017.
4
ACUTE CENTRAL SEROUS CHORIORETINOPATHY: Factors Influencing Episode Duration.急性中心性浆液性脉络膜视网膜病变:影响病程持续时间的因素
Retina. 2017 Oct;37(10):1905-1915. doi: 10.1097/IAE.0000000000001443.
5
BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.基线光谱域光学相干断层扫描高反射灶作为中心性浆液性脉络膜视网膜病变视觉预后和复发的预测指标
Retina. 2016 Jul;36(7):1372-80. doi: 10.1097/IAE.0000000000000929.
6
Topical nepafenac in treatment of acute central serous chorioretinopathy.局部用奈帕芬胺治疗急性中心性浆液性脉络膜视网膜病变。
Med Hypothesis Discov Innov Ophthalmol. 2013 Winter;2(4):96-101.
7
Correlation of spectral domain optical coherence tomography findings and visual acuity in central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的频域光学相干断层扫描结果与视力的相关性。
Retina. 2014 Apr;34(4):705-12. doi: 10.1097/IAE.0000000000000001.
8
Multimodal imaging of pigment epithelial detachment: a guide to evaluation.色素上皮脱离的多模态影像学:评估指南。
Retina. 2013 Oct;33(9):1735-62. doi: 10.1097/IAE.0b013e3182993f66.
9
Epidemiology of idiopathic central serous chorioretinopathy in Taiwan, 2001-2006: a population-based study.2001-2006 年台湾特发性中心性浆液性脉络膜视网膜病变的流行病学:一项基于人群的研究。
PLoS One. 2013 Jun 24;8(6):e66858. doi: 10.1371/journal.pone.0066858. Print 2013.
10
Central serous chorioretinopathy: update on pathophysiology and treatment.中心性浆液性脉络膜视网膜病变:发病机制和治疗的最新进展。
Surv Ophthalmol. 2013 Mar-Apr;58(2):103-26. doi: 10.1016/j.survophthal.2012.07.004.